Literature DB >> 7426276

Comparison of plasma and saliva levels of diazepam.

J J de Gier, B J t Hart, P F Wilderink, F A Nelemans.   

Abstract

1. Salivary, unbound and total plasma levels of diazepam have been compared in nineteen subjects. 2. Salivary diazepam levels were significantly higher (P < 0.001) than, but closely related to the corresponding unbound levels (r = 0.97) at 2.5-3 h after administration of the drug. 3. The results presented suggest that saliva levels can be used to predict the corresponding plasma levels at a given time, but there is no 1:1 relation between the unbound diazepam concentration in plasma and the saliva level of the drug.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7426276      PMCID: PMC1430038          DOI: 10.1111/j.1365-2125.1980.tb01732.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  14 in total

1.  The displacing effect of a fatty acid on the binding of diazepam to human serum albumin.

Authors:  E Tsutsumi; T Inaba; W A Mahon
Journal:  Biochem Pharmacol       Date:  1975-07-15       Impact factor: 5.858

2.  Sedatives and driving.

Authors:  J Plumb
Journal:  Br Med J       Date:  1976-11-06

3.  Plasma protein binding of diazepam and tolbutamide in chronic alcoholics.

Authors:  J J Thiessen; E M Sellers; P Denbeigh; L Dolman
Journal:  J Clin Pharmacol       Date:  1976-07       Impact factor: 3.126

Review 4.  Pharmacokinetic interpretation of data gathered during therapeutic drug monitoring.

Authors:  B H Dvorchik; E S Vesell
Journal:  Clin Chem       Date:  1976-06       Impact factor: 8.327

5.  Use of saliva in therapeutic drug monitoring.

Authors:  M G Horning; L Brown; J Nowlin; K Lertratanangkoon; P Kellaway; T E Zion
Journal:  Clin Chem       Date:  1977-02       Impact factor: 8.327

6.  Influence of pH on the benzodiazepine-human serum albumin complex. Circular dichroism studies.

Authors:  W Müller; U Wollert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

7.  The effect of Ca2+ on the binding of steroids to human serum albumin.

Authors:  M T Ryan; G Gibbs
Journal:  Biochim Biophys Acta       Date:  1970-10-27

8.  Evaluation of methods to determine protein-binding of drugs. Equilibrium dialysis, ultrafiltration, ultracentrifugation, gel filtration.

Authors:  H Kurz; H Trunk; B Weitz
Journal:  Arzneimittelforschung       Date:  1977-07

9.  Displacement of tolbutamide, glibencalmide and chlorpropamide from serum albumin by anionic drugs.

Authors:  K F Brown; M J Crooks
Journal:  Biochem Pharmacol       Date:  1976-05-15       Impact factor: 5.858

10.  Prolonged recovery after diazepam sedation: the influence of food, charcoal ingestion and injection rate on the effects of intravenous diazepam.

Authors:  K Korttila; M J Mattila; M Linnoila
Journal:  Br J Anaesth       Date:  1976-04       Impact factor: 9.166

View more
  6 in total

Review 1.  Interpretation of oral fluid tests for drugs of abuse.

Authors:  Edward J Cone; Marilyn A Huestis
Journal:  Ann N Y Acad Sci       Date:  2007-03-01       Impact factor: 5.691

Review 2.  Salivary biomarkers for clinical applications.

Authors:  Lei Zhang; Hua Xiao; David T Wong
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

Review 3.  Drug monitoring in nonconventional biological fluids and matrices.

Authors:  S Pichini; I Altieri; P Zuccaro; R Pacifici
Journal:  Clin Pharmacokinet       Date:  1996-03       Impact factor: 6.447

Review 4.  Pharmacokinetic studies in infants using minimal-risk study designs.

Authors:  Julie Autmizguine; Daniel K Benjamin; P Brian Smith; Mario Sampson; Philippe Ovetchkine; Michael Cohen-Wolkowiez; Kevin M Watt
Journal:  Curr Clin Pharmacol       Date:  2014

Review 5.  Therapeutic drug concentration monitoring using saliva samples. Focus on anticonvulsants.

Authors:  H Liu; M R Delgado
Journal:  Clin Pharmacokinet       Date:  1999-06       Impact factor: 6.447

Review 6.  Anticonvulsant drugs. An update.

Authors:  M J Eadie
Journal:  Drugs       Date:  1984-04       Impact factor: 9.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.